DE50106655D1 - NEW PYRIDINE-SUBSTITUTED PYRAZOLOPYRIDINE DERIVATIVES - Google Patents

NEW PYRIDINE-SUBSTITUTED PYRAZOLOPYRIDINE DERIVATIVES

Info

Publication number
DE50106655D1
DE50106655D1 DE50106655T DE50106655T DE50106655D1 DE 50106655 D1 DE50106655 D1 DE 50106655D1 DE 50106655 T DE50106655 T DE 50106655T DE 50106655 T DE50106655 T DE 50106655T DE 50106655 D1 DE50106655 D1 DE 50106655D1
Authority
DE
Germany
Prior art keywords
pyrazolopyridine derivatives
new pyridine
substituted pyrazolopyridine
substituted
pyridine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE50106655T
Other languages
German (de)
Inventor
Johannes-Peter Stasch
Achim Feurer
Stefan Weigand
Elke Stahl
Dietmar Flubacher
Cristina Alonso-Alija
Frank Wunder
Dieter Lang
Klaus Dembowsky
Alexander Straub
Elisabeth Perzborn
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Bayer Healthcare AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Healthcare AG filed Critical Bayer Healthcare AG
Priority to DE50106655T priority Critical patent/DE50106655D1/en
Priority claimed from PCT/EP2001/012969 external-priority patent/WO2002042301A1/en
Application granted granted Critical
Publication of DE50106655D1 publication Critical patent/DE50106655D1/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DE50106655T 2000-11-22 2001-11-09 NEW PYRIDINE-SUBSTITUTED PYRAZOLOPYRIDINE DERIVATIVES Expired - Lifetime DE50106655D1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DE50106655T DE50106655D1 (en) 2000-11-22 2001-11-09 NEW PYRIDINE-SUBSTITUTED PYRAZOLOPYRIDINE DERIVATIVES

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE10057753 2000-11-22
DE10131987A DE10131987A1 (en) 2000-11-22 2001-07-02 New pyridinyl-substituted pyrazolo (3,4-b) pyridine derivatives, are soluble guanylate cyclase stimulants useful e.g. for treating cardiovascular or central nervous system diseases, sexual dysfunction or inflammation
PCT/EP2001/012969 WO2002042301A1 (en) 2000-11-22 2001-11-09 Novel pyridine-substituted pyrazolopyridine derivatives
DE50106655T DE50106655D1 (en) 2000-11-22 2001-11-09 NEW PYRIDINE-SUBSTITUTED PYRAZOLOPYRIDINE DERIVATIVES

Publications (1)

Publication Number Publication Date
DE50106655D1 true DE50106655D1 (en) 2005-08-04

Family

ID=7664122

Family Applications (2)

Application Number Title Priority Date Filing Date
DE10131987A Withdrawn DE10131987A1 (en) 2000-11-22 2001-07-02 New pyridinyl-substituted pyrazolo (3,4-b) pyridine derivatives, are soluble guanylate cyclase stimulants useful e.g. for treating cardiovascular or central nervous system diseases, sexual dysfunction or inflammation
DE50106655T Expired - Lifetime DE50106655D1 (en) 2000-11-22 2001-11-09 NEW PYRIDINE-SUBSTITUTED PYRAZOLOPYRIDINE DERIVATIVES

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE10131987A Withdrawn DE10131987A1 (en) 2000-11-22 2001-07-02 New pyridinyl-substituted pyrazolo (3,4-b) pyridine derivatives, are soluble guanylate cyclase stimulants useful e.g. for treating cardiovascular or central nervous system diseases, sexual dysfunction or inflammation

Country Status (12)

Country Link
KR (1) KR20030065519A (en)
DE (2) DE10131987A1 (en)
DO (1) DOP2001000291A (en)
EC (1) ECSP034616A (en)
GT (1) GT200100235A (en)
HN (1) HN2001000261A (en)
MY (1) MY127212A (en)
PE (1) PE20020581A1 (en)
RU (1) RU2003118584A (en)
SV (1) SV2003000743A (en)
UA (1) UA74404C2 (en)
ZA (1) ZA200303887B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102485724B (en) * 2010-12-06 2015-08-12 中国人民解放军军事医学科学院毒物药物研究所 Substituted thiophene base pyrazolo-pyridines and medicinal use thereof
CR20190057A (en) 2011-11-25 2019-04-23 Adverio Pharma Gmbh Method for producing substituted 5-fluoro-1h-pyrazolopyridines
CN110022871A (en) * 2016-10-11 2019-07-16 拜耳制药股份公司 Combination product comprising sGC stimulant and mineralocorticoid receptor antagonists

Also Published As

Publication number Publication date
ECSP034616A (en) 2003-06-25
SV2003000743A (en) 2003-01-13
DE10131987A1 (en) 2002-05-23
ZA200303887B (en) 2004-06-21
PE20020581A1 (en) 2002-07-13
MY127212A (en) 2006-11-30
RU2003118584A (en) 2004-12-20
KR20030065519A (en) 2003-08-06
GT200100235A (en) 2002-06-25
HN2001000261A (en) 2002-01-30
DOP2001000291A (en) 2002-12-15
UA74404C2 (en) 2005-12-15

Similar Documents

Publication Publication Date Title
ATE298752T1 (en) NEW PYRIDINE-SUBSTITUTED PYRAZOLOPYRIDINE DERIVATIVES
DE50105334D1 (en) NEW CARBAMATE-SUBSTITUTED PYRAZOLOPYRIDINE DERIVATIVES
ATE271031T1 (en) NEW PHENYLPROPARGYLETHER DERIVATIVES
DE50202178D1 (en) NEW SULPHONATE-SUBSTITUTED PYRAZOLOPYRIDINE DERIVATIVES
DE50111292D1 (en) NEW SULFONAMIDE-SUBSTITUTED PYRAZOLOPYRIDINE DERIVATIVES
NO20032453D0 (en) Substituted imidazopyridines
DK1292604T3 (en) 2-aminocarbonyl-9H-purine derivatives
ATE288437T1 (en) TETRAHYDRO-HETEROCYCLOAZEPINYL-PYRIMIDINE DERIVATIVES E
ATE298332T1 (en) DECAHYDRO-ISOCHINOLINE DERIVATIVES
DE60119982D1 (en) HETEROZYKLYL ALKYLINDOLE OR AZAINDOLE AS 5-HYDROXYTRYPTAMINE-6 LIGANDS
DK1280809T3 (en) Antitumorecteinascidin derivatives
ATE334114T1 (en) SUBSTITUTED C-CYCLOHEXYLMETHYLAMIN DERIVATIVES
DE60111268D1 (en) NEW PULLEOMUTILINE DERIVATIVES
DE60103033D1 (en) NEW PHENYLHETEROALKYLAMINE DERIVATIVES
DK1322593T3 (en) O-substituted-6-methyl-tramadol derivatives
ATE282021T1 (en) SUBSTITUTED AMINOMETHYL-PHENYL-CYCLOHEXANE DERIVATIVES
ATE280752T1 (en) AMINOMETHYL-PHENYL-CYCLOHEXANONE DERIVATIVES
DE60126125D1 (en) NEW CARBAPENEM DERIVATIVES
DE50106655D1 (en) NEW PYRIDINE-SUBSTITUTED PYRAZOLOPYRIDINE DERIVATIVES
DE50112454D1 (en) SUBSTITUTED 5-AMINO-1-PENTEN-3-OL DERIVATIVES
ATE304007T1 (en) NEW INDOLE DERIVATIVES
DE50104434D1 (en) LACTAM-SUBSTITUTED PYRAZOLOPYRIDINE DERIVATIVES
ATE374776T1 (en) PYRROLOTRIAZOLOPYRIMIDINONE DERIVATIVES
NO20024393D0 (en) 2-sulphonylphenyl-4-one derivatives
FR2808616B1 (en) ROTARY ELECTROMAGNET

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT, 1335, DE